Lamotrigine controlled-release
At a glance
- Drug Originator GlaxoSmithKline
- Drug Class Antidepressants; Antiepileptic drugs; Chlorobenzenes; Mood stabilisers; Small molecules; Triazines
- Mechanism of Action Sodium channel antagonists
- USA Patent Applicants GLAXOSMITHKLINE LLC
- USA Patents 2
- NDAs 1
- International Patents 44
- Patent Applications 4,991
Disclaimer